Diamyd Medical
17.36
SEK
+1.05 %
DMYD B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
+1.05%
+5.6%
+5.6%
+29.94%
-9.39%
+102.1%
+16.75%
-2.84%
+475.46%
Diamyd Medical is a diabetes company. The company develops the diabetes vaccine Diamyd® with the active ingredient GAD, which has the potential to become a key piece of the puzzle of a future solution to prevent, treat or cure type 1 diabetes and other forms of diabetes. Diamyd Medical has independently pursued the development of the diabetes vaccine Diamyd® to global Phase III trial.
Read moreMarket cap
1.81B SEK
Turnover
2.45M SEK
Revenue
130K
EBIT %
-112,746.15 %
P/E
-
Dividend yield-%
-
Financial calendar
9/4
2025
Interim report Q2'25
25/6
2025
Interim report Q3'25
8/10
2025
Annual report '25
ShowingAll content types
Diamyd Medical AB: Quarterly Report 1 24/25
Diamyd Medical AB: Delårsrapport 1 24/25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools